LF
LEGN icon

Lansforsakringar Fondforvaltning’s Legend Biotech LEGN Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
11,000
-4,000
-27% -$108K ﹤0.01% 585
2026
Q1 		$271K Hold
15,000
– – ﹤0.01% 548
2025
Q4 		$326K Buy
15,000
+3,000
+25% +$85.9K ﹤0.01% 539
2025
Q3 		$391K Hold
12,000
– – ﹤0.01% 526
2025
Q2 		$426K Sell
12,000
-15,810
-57% -$512K ﹤0.01% 526
2025
Q1 		$944K Sell
27,810
-283
-1% -$10.1K 0.01% 519
2024
Q4 		$914K Buy
+28,093
New +$1.16M 0.01% 520

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Lansforsakringar Fondforvaltning's LEGN Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Legend Biotech (LEGN) stake by 27% in Q2 2026, selling an estimated $108K and leaving 11,000 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Lansforsakringar Fondforvaltning first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $944K in Q1 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 11,000 shares of Legend Biotech worth $318K as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 4,000 Legend Biotech shares in Q2 2026, an estimated $108K.
  • Legend Biotech made up ﹤0.01% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #585 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Legend Biotech position peaked at $944K in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.